Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥12)-core prostate biopsy

Prostate

Volumn 72, Issue 1, 2012, Pages 51-57

  Hong, Sung Kyu ^a   Oh, Jong Jin ^a   Byun, Seok Soo ^a   Hwang, Sung Il ^a   Lee, Hak Jong ^a   Choe, Gheeyoung ^a   Lee, Sang Eun ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

biopsy; diabetes mellitus; prostate; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER GRADING; DIABETES MELLITUS; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; ECHOGRAPHY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOPSY; DIABETES MELLITUS; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 81855194458     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21405     Document Type: Article

References (36)

1. Bonovas S, Filioussi K, Tsantes A,. Diabetes mellitus and risk of prostate cancer: A meta-analysis. Diabetologia 2004; 47: 1071-1078.
2. Kasper JS, Giovannucci E,. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2056-2062.
3. Baradaran N, Ahmadi H, Salem S, Lotfi M, Jahani Y, Baradaran N, Mehrsai AR, Pourmand G,. The protective effect of diabetes mellitus against prostate cancer: Role of sex hormones. Prostate 2009; 69: 1744-1750.
4. Kasper JS, Liu Y, Giovannucci E,. Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 2009; 124: 1398-1403.
5. Chan JM, Latini DM, Cowan J, Duchane J, Carroll PR,. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control 2005; 16: 789-797.
6. Gong Z, Neuhouser ML, Goodman PJ, Hsing AW, Schatzkin A, Chang SC, Huang WY, Weiss JM, Danforth KN, Grubb RL III, Andriole GL,. Prostate, Lung, Colorectal, and Ovarian Trial Project Team. Obesity, diabetes, and risk of prostate cancer: Results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2006; 15: 1977-1983.
7. Leitzmann MF, Ahn J, Albanes D, Hsing AW, Schatzkin A, Chang SC, Huang WY, Weiss JM, Danforth KN, Grubb RL 3rd, Andriole GL, Prostate, Lung, Colorectal, and Ovarian Trial Project Team. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control 2008; 19: 1267-1276.
8. Werny DM, Saraiya M, Gregg EW,. Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002. Am J Epidemiol 2006; 164: 978-983.
9. Fowke JH, Motley SS, Cookson MS, Concepcion R, Chang SS, Wills ML, Smith JA Jr., The association between body size, prostate volume and prostate-specific antigen. Prostate Cancer Prostatic Dis 2007; 10: 137-142.
10. Berger AP, Deibl M, Halpern EJ, Lechleitner M, Bektic J, Horninger W, Fritsche G, Steiner H, Pelzer A, Bartsch G, Frauscher F,. Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia. Diabetologia 2005; 48: 784-789.
11. Hammarsten J, Hogstedt B,. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001; 39: 151-158.
12. Presti JC,. Prostate biopsy: Current status and limitations. Rev Urol 2007; 9: 93-98.
13. Fine SW, Epstein JI,. A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score. J Urol 2008; 179: 1335-1338.
14. World Health Organization, Western Pacific Region, International Association for the Study of Obesity. The Asia-Pacific perspective: Redefining obesity and its treatment. Sydney, Australia: Health Communications Australia Pty, Limited; 2000.
15. Van Houwelingen JC, Le Cessie S,. Predictive value of statistical models. Stat Med 1990; 9: 1303-1325.
16. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L,. Risk factors for malignant diseases: A cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 1997; 6: 863-873.
17. Hsing AW, Chua S Jr, Gao YT, Gentzschein E, Chang L, Deng J, Stanczyk FZ,. Prostate cancer risk and serum levels of insulin and leptin: A population-based study. J Natl Cancer Inst 2001; 93: 783-789.
18. Hsing AW, Gao YT, Chua S Jr, Deng J, Stanczyk FZ,. Insulin resistance and prostate cancer risk. J Natl Cancer Inst 2003; 95: 67-71.
19. Stattin P, Soderberg S, Hallmans G, Bylund A, Kaaks R, Stenman UH, Bergh A, Olsson T,. Leptin is associated with increased prostate cancer risk: A nested case-referent study. J Clin Endocrinol Metab 2001; 86: 1341-1345.
20. Jayachandran J, Aronson WJ, Terris MK, Presti JC Jr, Amling CL, Kane CJ, Freedland SJ,. Diabetes and outcomes after radical prostatectomy: Are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database. Cancer Epidemiol Biomarkers Prev 2010; 19: 9-17.
21. Abdollah F, Briganti A, Suardi N, Gallina A, Capitanio U, Salonia A, Cestari A, Guazzoni G, Rigatti P, Montorsi F,. Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? Prostate Cancer Prostatic Dis 2011; 14: 74-78. DOI: 10.1038/pcan.2010.41.
22. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR,. Baltimore longitudinal study of aging: Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 2001; 86: 724-731.
23. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P,. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 5462-5468.
24. Svartberg J, Jenssen T, Sundsfjord J, Jorde R,. The associations of endogenous testosterone and sex hormone-binding globulin with glycosylated hemoglobin levels, in community dwelling men. The Tromso Study. Diabetes Metab 2004; 30: 29-34.
25. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM,. Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91: 1995-2010.
26. Yamamoto S, Yonese J, Kawakami S, Ohkubo Y, Tatokoro M, Komai Y, Takeshita H, Ishikawa Y, Fukui I,. Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. Eur Urol 2007; 52: 696-701.
27. Xylinas E, Ploussard G, Durand X, Fabre A, Salomon L, Allory Y, Vordos D, Hoznek A, Abbou CC, De La Taille A,. Low pretreatment total testosterone (<3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancer. BJU Int 2010; Nov 2. DOI: 10.1111/j.1464-410X.2010.09816.x.
28. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey JV Jr, Helzlsouer K, Rinaldi S, Riboli E, Kaaks R, Janssen JA, Wildhagen MF, Schroder FH, Platz EA, Pollak M, Giovannucci E, Schaefer C, Quesenberry CP Jr, Vogelman JH, Severi G, English DR, Giles GG, Stattin P, Hallmans G, Johansson M, Chan JM, Gann P, Oliver SE, Holly JM, Donovan J, Meyer F, Bairati I, Galan P,. Insulin-like growth factors, their binding proteins, and prostate cancer risk: Analysis of individual patient data from 12 prospective studies. Ann Intern Med 2008; 149: 461-471.
29. Roddam AW, Allen NE, Appleby P, Key TJ,. Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies. J Natl Cancer Inst 2008; 100: 170-183.
30. Schumacher FR, Cheng I, Freedman ML, Mucci L, Allen NE, Pollak MN, Hayes RB, Stram DO, Canzian F, Henderson BE, Hunter DJ, Virtamo J, Manjer J, Gaziano JM, Kolonel LN, Tjønneland A, Albanes D, Calle EE, Giovannucci E, Crawford ED, Haiman CA, Kraft P, Willett WC, Thun MJ, Le Marchand L, Kaaks R, Feigelson HS, Bueno-de-Mesquita HB, Palli D, Riboli E, Lund E, Amiano P, Andriole G, Dunning AM, Trichopoulos D, Stampfer MJ, Key TJ, Ma J,. A comprehensive analysis of common IGF1, IGFBP1, and IGFBP3 genetic variation with prospective IGF-1 and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet 2010; 19: 3089-3101.
31. Gu F, Schumacher FR, Canzian F, Allen NE, Albanes D, Berg CD, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Buring JE, Chabbert-Buffet N, Chanock SJ, Clavel-Chapelon F, Dumeaux V, Gaziano JM, Giovannucci EL, Haiman CA, Hankinson SE, Hayes RB, Henderson BE, Hunter DJ, Hoover RN, Johansson M, Key TJ, Khaw KT, Kolonel LN, Lagiou P, Lee IM, LeMarchand L, Lund E, Ma J, Onland-Moret NC, Overvad K, Rodriguez L, Sacerdote C, Sánchez MJ, Stampfer MJ, Stattin P, Stram DO, Thomas G, Thun MJ, Tjønneland A, Trichopoulos D, Tumino R, Virtamo J, Weinstein SJ, Willett WC, Yeager M, Zhang SM, Kaaks R, Riboli E, Ziegler RG, Kraft P,. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer. Cancer Epidemiol Biomarkers Prev 2010; 19: 2877-2887.
32. Gill JK, Wilkens LR, Pollak MN, Stanczyk FZ, Kolonel LN,. Androgens, growth factors, and risk of prostate cancer: The Multiethnic Cohort. Prostate 2010; 70: 906-915.
33. Hong SK, Lee ST, Kim SS, Min KE, Byun SS, Cho SY, Choe G, Lee SE,. Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer. Prostate 2009; 69: 820-826.
34. Kim HS, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ,. Glycemic control and prostate cancer progression: Results from the SEARCH database. Prostate 2010; 70: 1540-1546.
35. Li Q, Kuriyama S, Kakizaki M, Yan H, Sone T, Nagai M, Sugawara Y, Ohmori-Matsuda K, Hozawa A, Nishino Y, Tsuji I,. History of diabetes mellitus and the risk of prostate cancer: The Ohsaki Cohort Study. Cancer Causes Control 2010; 21: 1025-1032.
36. Shin BS, Hwang EC, Im CM, Kim SO, Jung SI, Kang TW, Kwon DD, Park K, Ryu SB,. Is a decreased serum testosterone level a risk factor for prostate cancer? A cohort study of Korean men. Korean J Urol 2010; 51: 819-823.